Cannabis & Hemp Stocks Investment Tools – Schedule Demo Now!

Hempstract Labs RVDO

Hempstract Labs / Riverdale Oil & Gas Corp.

Riverdale Oil & Gas Corp. used to be an oil and gas acquisition company. Now they have pivoted into the hemp industry with their acquisition of Hempstract LLC out of Washington. The company was founded in 2007 and is headquartered in Austin, TX.

Is HPST Hemp Stock a strong BUY and HOLD?

HPST Fundamental Analysis


HQ: Austin, TX, USA
Founded: 2007
Symbol: HPST (OTC)

Focus: Neutral

RVDO was a non-operating oil and gas company that outsourced most of it work. Their projects included natural gas exploration, development, and production, mainly in south Texas and the Gulf Coast. They also held gas leases.

On August 6th, 2020 they announced an asset purchase agreement with Hempstract, LLC to take control of 3 kg of CBD isolate and all equipment held at Hempstract’s Washington location. The sale price was $36.8 million in an all-stock deal.

Size: Weak

Market Cap: $6.31 mil
Enterprise Value: $6.1 mil
Number of Employees: 3


Operations: Neutral

Cultivation: None
Current production: Hempstract produces THC-free CBD isolate and distillate oils along with whole hemp plant extracts to be used downstream in topicals and pet products.

Distribution: None
Direct sales: Yes

Store networks: Signed a recent tolling (concentrate manufacturing) agreement with IsoPhlora, Inc. a Portland, Oregon-based company.

Hempstract with retain 40% of finished products from tolling agreement. This type of arrangement is typical for tolling operators.

Vertically integrated: No
Horizontally diversified: No

Financials: Weak

Revenue (2020): RVDO reported no revenue in Q1 and Q2 2020
Shares Outstanding (diluted): 26.7 million
Return on Equity: -56.6%

Management: Neutral

CEO: Richard Hawkins
Secretary: Michael Glazer (resigned)
VP: Linda Ellis

In Feb. 2020, Manufacturing 360 acquired the controlling interest of RVDO and Ron Herzfeld resigned as President and Michael Glazer resigned as secretary. The three Hempstract employees paid were Justin Costello, Gregory Haynes, and Kim Melbye. Dr. Todd Talley will be the CSO, Katrina Costello the President, and Richard Hawkins will continue as CEO.

Branding: Weak

They have no branded products as RVDO or Hempstract.

Valuation: Weak

Current share price: $0.236
Price to Sales: NA
52 week low/high: $0.004-$2.17
EV/Revenue: NA
Price/Book: NA

Financing: Weak

RVDO reported losses of $700k in 2020. They had no money and were failing in oil and gas.

HPST Technical Analysis

Should I buy Hempstract Labs Hemp Stock?

Follow Stephen Goldman as he evaluates Hempstract Labs (HPST) using the MACD, CCI, and Bollinger bands to learn about trading opportunities with RVDO during the fundamental “pop.”

Remember sound cannabis stock trading strategies include both Fundamental Analysis and Technical Analysis.

52 week Range -

Bottom Line: Is HPST Hemp Stock a Buy?

Recommendation: Weak

Riverdale Oil & Gas Corp was an exploratory oil and natural gas company active in South Texas and the Gulf Coast. They were struggling. They had 5 leased wells and all were either lost or reported very low production. In fact, they had reported losses of around $700k every year for the last 11 years. Not great.

Obviously, they needed a pivot and the hemp industry provided just that. In February they started due diligence on Hempstract LLC, a Warden, Washington business that produced CBD distillate oil and THC-free CBD isolate for use in topical and infused products. In August they closed on that deal which included assets of 3.1 kg of CBD isolate and manufacturing equipment work $750k. Hempstract was renovating an old missile facility to scale up production.

This brought a lot of excitement to the investing world. It was not warranted. There are 100s of companies in the United States doing what Hempstract was doing. Most are privately held but some are not. Hempstract does have some tolling agreements but that is about it. Given the market saturation and ongoing constriction that is happening in the CBD industry, it does not look promising. The HPST stock did pop all the way to nearly $2.00 but it is now back down to where it started at $0.24. Look for it to drop even more.

The company has zero revenue. Their Annual Report Form 10-K filed with the SEC actually says “At this time, we have not identified specific planned revenue streams. During the years ended April 30, 2020, and 2019, we did not recognize any revenue.” The company hasn’t made a dollar in over 2 years. They’ve signed only non-binding letters of intent and have followed through with no transactions. All this “activity” is good for press releases which may drive stock prices up. Once the stock price goes up nothing much else happens. The company has yet to act on any of these letters of intent. Most are just press releases.

For all the reasons above, we rate this stock as Weak but check out our other featured companies for many other winners in the cannabis and hemp industry.

Symbol Name Last Price Change % Change
Cannin Hemp Stocks Day Trader Membership

Is It a Good Idea to Buy Harvest One Stock Now?

Is It a Good Idea to Buy Harvest One Stock Now? Along with the technology sector, the COVID-19 pandemic has popularized the health and wellness industry. Harvest One (HRVOF) operates in this space and is primarily focused on improving sleep, and healing pain and...

Is GrowGeneration the Best Cannabis Stock for 2020?

Is GrowGeneration the Best Cannabis Stock for 2020? Cannabis stocks with 600% gains tend to get investors prompt attention. GrowGeneration (GRWG), a Denver-based hydroponics, and organic specialty products company is certainly living up to its name in 2020 with an...

Is Aphria Stock a Buy Right Now?

Is Aphria Stock a Buy Right Now? With a market capitalization of about $2.94 billion, Canada-based Aphria, Inc. (APHA) is one of the biggest names in the cannabis industry. Like most other cannabis stocks, Aphria has yet to demonstrate consistent profits and is a...

Organigram (OGI) Reports Q4 2020 Results

Organigram (OGI) Reports Q4 2020 Results Organigram (OGI) just reported its Q4 2020 results and here are the key highlights from the earnings call: Q4 2020 net revenue increased 25% to $20.4 million from $16.3 million in Q4 2019 Q4 2020 gross revenue increased 32% to...

Buy Alert: This Cannabis Stock Is Up 90% in November

Buy Alert: This Cannabis Stock Is Up 90% in November When stock prices spike, it makes you wonder whether it is a knee-jerk reaction to a market movement or announcement or some major news that you may have missed. November has been a particularly good month for...

Neptune Wellness: Will this Hemp Stock Gain Momentum in 2021?

Neptune Wellness: Will this Hemp Stock Gain Momentum in 2021? The health and wellness sector is a smart space to operate in as it's a $4.2 Trillion dollar industry. Hemp stocks with a health and wellness focus, such as, Neptune Wellness Solutions (NEPT) operate in...

Planet 13’s Q3: Out of this World

Planet 13's Q3: Out of this World Planet 13 Announces Record Third Quarter 2020 Financial Results Q3 2020 Revenue of $22.8 million; Adjusted EBITDA of $6.2 million All figures are reported in United States dollars ($) unless otherwise indicated LAS VEGAS, NV /...

Decibel Announces Net Revenue Increase of 29%

Decibel Announces Net Revenue Increases of 29% from Prior Quarter, First Period of Positive Adjusted EBITDA and Results of Annual Meeting CALGARY, AB, Nov. 25, 2020 /CNW/ - Decibel Cannabis Company Inc. (the "Company" or "Decibel") (TSXV: DB) (OTCQB: DBCCF), a premium...

Cresco: Q3 Results Make it a Smart Value Buy

Cresco: Q3 Results Make it a Smart Value Buy Canadian cannabis stocks continue to dominate the headlines as several of these stocks are solid buys. Of course, there are great cannabis and hemp stocks in the U.S. as well. A few of these U.S.-based stocks are great...

3 Strong Buy and Hold Hemp Stocks for 2021

3 Strong Buy and Hold Hemp Stocks for 2021 With over 95% ballots reporting in most swing states, a Biden/Harris administration looks more likely with every passing day. While plenty of uncertainty over the legalization of marijuana in the U.S. remains, the industry...